Evaluation of best supportive care and systemic chemotherapy as treatment stratified according to the retrospective peritoneal surface disease severity score (PSDSS) for peritoneal carcinomatosis of colorectal origin.

Evaluation of best supportive care and systemic chemotherapy as treatment stratified according to the retrospective peritoneal surface disease severity score (PSDSS) for peritoneal carcinomatosis of colorectal origin.

Item

http://www.wikidata.org/entity/Q33777576

Q33777576

about

Multimodality treatment strategies have changed prognosis of peritoneal metastases Treatment of peritoneal metastases from colorectal cancer Multimodal treatment approaches for peritoneal carcinosis in colorectal cancer Therapeutic options for peritoneal metastasis arising from colorectal cancer Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial.A Phase II Study of Modified FOLFOX4 for Colorectal Cancer Patients with Peritoneal Carcinomatosis.Intraperitoneal chemotherapy as adjuvant treatment to prevent peritoneal carcinomatosis of colorectal cancer origin: a systematic review.BEV-IP: Perioperative chemotherapy with bevacizumab in patients undergoing cytoreduction and intraperitoneal chemoperfusion for colorectal carcinomatosis.Prognostic Relevance of the Peritoneal Surface Disease Severity Score Compared to the Peritoneal Cancer Index for Colorectal Peritoneal Carcinomatosis.Multidisciplinary Treatment for Colorectal Peritoneal Metastases: Review of the Literature.Surgery for colorectal peritoneal carcinomatosis.Cytoreductive surgery and intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis from colorectal origin.The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with Colorectal Cancer with Peritoneal Carcinomatosis.Recommendations and consensus on the treatment of peritoneal metastases of colorectal origin: a systematic review of national and international guidelines.A Temperature of 40 °C Appears to be a Critical Threshold for Potentiating Cytotoxic Chemotherapy In Vitro and in Peritoneal Carcinomatosis Patients Undergoing HIPEC.Impact of peritoneal carcinomatosis in the disease history of colorectal cancer management: a longitudinal experience of 2406 patients over two decades The American Society of Peritoneal Surface Malignancies Multi-Institution evaluation of 1,051 advanced ovarian cancer patients undergoing cytoreductive surgery and HIPEC: An introduction of the peritoneal surface disease severity score.Early Postoperative Chemotherapy After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Isolated Peritoneal Carcinomatosis of Colon Cancer: A Multicenter Study.Colorectal cancer at high risk of peritoneal metastases: long term outcomes of a pilot study on adjuvant laparoscopic HIPEC and future perspectives.Peritoneal carcinomatosis of colorectal origin: Incidence, prognosis and treatment options.Evaluation of a new staging classification and a Peritoneal Surface Disease Severity Score (PSDSS) in 229 patients with mucinous appendiceal neoplasms with or without peritoneal dissemination.The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery.Clinical studies in CRS and HIPEC: Trials, tribulations, and future directions-A systematic review.Unresectability during open surgical exploration in planned cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.Survival and Prognostic Factors for Metachronous Peritoneal Metastasis in Patients with Colon Cancer.Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasis.Safety of intraoperative chemotherapy with 5-FU for colorectal cancer patients receiving curative resection: a randomized, multicenter, prospective, phase III IOCCRC trial (IOCCRC).

P2860

Q26769938-9CCC1CE9-452B-4226-96B0-2CF85FF252B8 Q26783662-A531168E-23C1-436D-9136-3835906B7CCB Q26852135-627DE77F-8A88-4F93-AD40-874772C6A04C Q28067123-3EB70538-D86F-4313-8A44-9C045F007E41 Q34477640-53F12C1B-24F6-4406-A8B9-1625D0276A79 Q35661054-358C44B1-9419-4AF5-92EA-F14860F34BFB Q35678364-94620EBC-1839-4579-80DF-4B6268D47236 Q35870363-3134D184-AFBF-40C9-A3FC-A00225D374DC Q36661280-651EFF33-7D57-48A3-AB41-8D32480F626E Q37571642-AD164C3A-6315-46A3-B38F-6C9CB3F29388 Q37977476-9539EA6E-CD87-4978-B4D4-5F84C96A0DE2 Q38112342-C3D2416E-44FB-487B-82EE-21905B579E5E Q38214032-5CE89741-F86C-4CF5-A57D-73174F774C97 Q38778938-FF195D20-DF76-48DC-ADC3-B5BD534C8905 Q38836835-40EE1F5A-1AF7-4B5C-9494-FCF0EE7AB048 Q39922489-781DC7E7-BED7-4000-B4B9-DC7E618348C2 Q40507435-333ADD9A-5B76-41CA-921C-992E76DD91F9 Q41203836-95748F54-348D-40CA-A88E-2554E76F6FF0 Q41612691-BEAE7F70-F39F-43A7-AB4F-98AEFE1BA181 Q42398293-FD2B02AA-48B4-4F81-B8AB-FF6A8C38773E Q44809962-207EA765-D0E3-49E6-8FEC-899FF2857989 Q45823091-14B4EB4D-FCCE-4007-BF14-24BD0B7C101C Q47849422-768E4E93-4F84-4057-9E61-BB46A55F3939 Q50578314-227D7CC2-D600-4CEA-A69A-B723BD922C10 Q51000263-A1E0C44A-B344-4D4A-B3D9-B6749D4663C6 Q51709594-B8185B8D-61B7-4233-A68E-7FD8C374F67F Q53093164-003DF82F-22DF-4D91-B9E4-82FE46A46448

P2860

Evaluation of best supportive care and systemic chemotherapy as treatment stratified according to the retrospective peritoneal surface disease severity score (PSDSS) for peritoneal carcinomatosis of colorectal origin.

Item

http://www.wikidata.org/entity/Q33777576

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu